Installation
About
This workflow takes analyte levels from two different types of analytes (e.g. gene expression and metabolite abundance), meta-information on each analyte type, and sample outcome and metadata to identify analyte pairs that are significantly associated with a continuous or discrete outcome (e.g. drug response or tumor type). The following references describe the methods in this package: (1) Jalal K. Siddiqui, et al. (2018) doi:10.1186/s12859-018-2085-6, (2) Andrew Patt, et al. (2019) doi:10.1007/978-1-4939-9027-6_23.
Key Metrics
Downloads
Yesterday | 2 0% |
Last 7 days | 9 -25% |
Last 30 days | 42 -19% |
Last 90 days | 155 -70% |
Last 365 days | 1.864 +34% |